Physician profile
Emily E Wikner
NPI 1053871012
$933.60
in general payments reported to CMS, 2019-2025
10 companies · $471 in 2025
The $471 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $122 · 2022: $104 · 2023: $80.85 · 2024: $156 · 2025: $471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $707.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $226.96 | 2025 | Dupixent |
| Medtronic, INC. | $168.28 | 2023-2025 | Nim Vital, Propel |
| Glaxosmithkline, LLC. | $147.89 | 2021-2022 | |
| Karl Storz Endoscopy-America | $128.23 | 2022-2025 | |
| Inspire Medical Systems, INC. | $71.59 | 2024 | Inspire |
| Olympus America INC. | $61.84 | 2023 | Rhino-Laryngo Videoscope |
| Stryker Corporation | $49.61 | 2022 | |
| Acera Surgical, INC. | $39.54 | 2025 | Restrata Wound Matrix |
| Optinose US, INC. | $25.56 | 2024 | |
| Regeneron Pharmaceuticals, INC. | $14.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Wikner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.